Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T19:49:34.316Z.
Consensus retrieved: unavailable. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T19:49:34.316Z.
Quote observation: 2026-10-06T19:45:21.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 55640ef368038461e83fdf3019caf8b3f4a76b6c39ddb69408046ed15845a2bf
FORWARD PE RATIO
N/A
China SXT Pharmaceuticals, Inc.
Market Cap
$715847.00
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| China SXT Pharmaceuticals, Inc. (SXTC) | $715847.00 | N/A |
| CDT Equity Inc. (CDT)vs › | $695120.00 | N/A |
| Ridgetech, Inc. (RDGT)vs › | $814420.00 | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $823632.00 | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $835190.00 | N/A |
| Bone Biologics Corporation (BBLG)vs › | $850879.00 | N/A |
| HCW Biologics Inc. (HCWB)vs › | $566203.00 | N/A |
| Sunshine Biopharma, Inc. (SBFM)vs › | $891393.00 | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | N/A |
| VivoSim Labs, Inc. (VIVS)vs › | $527596.00 | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus fiscal-year EPS
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
